瘤炎症中的PI3Kγ:弥合免疫反应和癌症进展-一篇小小的评论
Anghesom Ghebremedhin1,2, Judith A Varner1,2
1Moores Cancer Center, University of California, San Diego, California, USA.
Immunology
|May 28, 2025
概括
酸丁醇3-酶 (PI3Kγ) 通过影响免疫细胞驱动瘤炎症和进展. 向PI3Kγ提供了一种有希望的策略,可以抑制癌症生长并减少炎症.
科学领域:
- 在瘤学瘤学.
- 免疫学 免疫学 免疫学
- 分子生物学分子生物学
背景情况:
- 酸氨基3-激酶 (PI3Kγ) 是炎症和免疫反应的关键调节者.
- PI3Kγ 影响髓状细胞活动,有助于瘤的进展和转移.
- 瘤微环境在很大程度上是由PI3Kγ介导的炎症过程塑造的.
研究的目的:
- 审查PI3Kγ在瘤相关炎症中的多样性作用.
- 突出PI3Kγ在免疫细胞两极分化和细胞因子产生中的作用.
- 探索针对PI3Kγ在癌症治疗中的治疗潜力.
主要方法:
- 对研究PI3Kγ在癌症中的研究的文献综述.
- 分析PI3Kγ在免疫细胞贩运和功能中的作用.
- 检查PI3Kγ对瘤细胞-干相互作用的影响.
主要成果:
- 在瘤微环境中,PI3Kγ促进髓状细胞的招募和激活.
- PI3Kγ 影响细胞因子,加剧与瘤相关的炎症.
- PI3Kγ活性与瘤细胞的增殖,存活和转移有关.
结论:
- PI3Kγ是癌症炎症的关键调解者.
- 向PI3Kγ是一个可行的治疗策略,可以抑制瘤生长.
- 调节PI3Kγ可以减少由炎症驱动的瘤发生,并改善癌症治疗结果.
相关概念视频
PI3K/mTOR/AKT Signaling Pathway
4.0K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
4.0K
Interactions Between Signaling Pathways
6.6K
Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
6.6K
mTOR Signaling and Cancer Progression
3.9K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.9K
Activation of Integrins
3.6K
Integrins bind ligands and transmit information from outside the cell to inside or vice-versa through an "outside-in signaling" or "inside-out signaling."
In "outside-in signaling," external factors in the extracellular space bind to exposed ligand binding sites on integrins. This causes the inactive protein to undergo a conformational change to become active. Integrins are often clustered on the cell membrane. Repetitive and regularly spaced ligand binding...
In "outside-in signaling," external factors in the extracellular space bind to exposed ligand binding sites on integrins. This causes the inactive protein to undergo a conformational change to become active. Integrins are often clustered on the cell membrane. Repetitive and regularly spaced ligand binding...
3.6K
The Tumor Microenvironment
6.8K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.8K
The JAK-STAT Signaling Pathway
9.3K
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...
9.3K


